{"id":"halopropane","rwe":[{"pmid":"12834356","year":"2003","title":"Steady-state and pre-steady-state kinetic analysis of halopropane conversion by a rhodococcus haloalkane dehalogenase.","finding":"","journal":"Biochemistry","studyType":"Clinical Study"},{"pmid":"12116402","year":"2002","title":"Ab Initio calculations of the stabilization energies of the conformational and the structural isomers of C(3)H(7)X where X = F, Cl, and Br.","finding":"","journal":"Journal of computational chemistry","studyType":"Clinical Study"},{"pmid":"29711969","year":"2001","title":"Butane-2,3-Diacetal-Desymmetrized Glycolic Acid-A New Building Block for the Stereoselective Synthesis of Enantiopure α-Hydroxy Acids.","finding":"","journal":"Angewandte Chemie (International ed. in English)","studyType":"Clinical Study"},{"pmid":"3044786","year":"1988","title":"Mutagenicity of halogenated propanes and their methylated derivatives.","finding":"","journal":"Environmental and molecular mutagenesis","studyType":"Clinical Study"},{"pmid":"4957066","year":"1966","title":"Neural factors affecting cardiac arrhythmias induced by halopropane.","finding":"","journal":"The Journal of pharmacology and experimental therapeutics","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"tebron","offLabel":[],"synonyms":["halopropane","tebron"],"timeline":[],"approvals":[],"brandName":"Tebron","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Think of it like a key fitting into a lock. Tebron is like the key, and the target is like the lock. When the key fits into the lock, it can turn the lock and change the way the body works.","oneSentence":"Tebron works by binding to a specific target in the body, although the exact mechanism is unclear.","technicalDetail":"The exact mechanism of action of Tebron is unknown, but it is believed to involve binding to a specific protein or receptor in the body, potentially altering signaling pathways or cellular function."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3457","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=halopropane","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:51:32.931233","biosimilars":[],"competitors":[],"genericName":"halopropane","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"3DC4A5894W","CHEBI":"CHEBI:134849","UMLSCUI":"C0603331","PUBCHEM_CID":"69623","MESH_SUPPLEMENTAL_RECORD_UI":"C007901"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":12,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"2003 Jul 8","pmid":"12834356","title":"Steady-state and pre-steady-state kinetic analysis of halopropane conversion by a rhodococcus haloalkane dehalogenase.","journal":"Biochemistry"},{"date":"2002 Jul 30","pmid":"12116402","title":"Ab Initio calculations of the stabilization energies of the conformational and the structural isomers of C(3)H(7)X where X = F, Cl, and Br.","journal":"Journal of computational chemistry"},{"date":"2001 Aug 3","pmid":"29711969","title":"Butane-2,3-Diacetal-Desymmetrized Glycolic Acid-A New Building Block for the Stereoselective Synthesis of Enantiopure α-Hydroxy Acids.","journal":"Angewandte Chemie (International ed. in English)"},{"date":"1988","pmid":"3044786","title":"Mutagenicity of halogenated propanes and their methylated derivatives.","journal":"Environmental and molecular mutagenesis"},{"date":"1966 Apr","pmid":"4957066","title":"Neural factors affecting cardiac arrhythmias induced by halopropane.","journal":"The Journal of pharmacology and experimental therapeutics"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Tebron, also known as halopropane, is a small molecule modality with unknown target and drug class. Its commercial status is unclear, and it is not known whether it is FDA approved or off-patent. There is limited information available on Tebron's approved indications, half-life, bioavailability, and generic manufacturers. Further research is needed to understand the pharmacology and clinical applications of Tebron. As a result, key safety considerations and potential side effects are also unknown.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}